Analysis of Gene Expression Data from Non-Small Cell Lung Carcinoma Cell Lines Reveals Distinct Sub-Classes from Those Identified at the Phenotype Level

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Dalby, Andrew R ^a   Emam, Ibrahim ^b   Franke, Raimo ^c  

^a UNIVERSITY OF WESTMINSTER   (United Kingdom)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^c HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; GENE CLUSTER; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC HETEROGENEITY; GENETIC VARIABILITY; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; PHENOTYPE; QUALITY CONTROL; RNA DEGRADATION; SIGNAL TRANSDUCTION; TRANSCRIPTOMICS;

ARTIFACTS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE; CELL LINE, TUMOR; CLUSTER ANALYSIS; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MODELS, GENETIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; QUALITY CONTROL; TUMOR MARKERS, BIOLOGICAL;

EID: 84870272739     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050253     Document Type: Article

References (36)

1. Gazdar AF, Gao B, Minna JD, (2010) Lung cancer cell lines: Useless artifacts or invaluable tools for medical science? Lung Cancer 68: 309-318 doi:10.1016/j.lungcan.2009.12.005.
2. Gazdar AF, Girard L, Lockwood WW, Lam WL, Minna JD, (2010) Lung cancer cell lines as tools for biomedical discovery and research. J Natl Cancer Inst 102: 1310-1321 doi:10.1093/jnci/djq279.
3. Gottschling S, Jauch A, Kuner R, Herpel E, Mueller-Decker K, et al. (2012) Establishment and comparative characterization of novel squamous cell non-small cell lung cancer cell lines and their corresponding tumor tissue. Lung Cancer 75: 45-57 doi:10.1016/j.lungcan.2011.05.020.
4. Curtis C, Shah SP, Chin S-F, Turashvili G, Rueda OM, et al. (2012) The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 486: 346-352 doi:10.1038/nature10983.
5. Powell AA, Talasaz AH, Zhang H, Coram MA, Reddy A, et al. (2012) Single cell profiling of circulating tumor cells: transcriptional heterogeneity and diversity from breast cancer cell lines. PLoS ONE 7: e33788 doi:10.1371/journal.pone.0033788.
6. Lukk M, Kapushesky M, Nikkilä J, Parkinson H, Goncalves A, et al. (2010) A global map of human gene expression. Nat Biotechnol 28: 322-324 doi:10.1038/nbt0410-322.
7. Macmillan Cancer Support (2012) Living after diagnosis: Median cancer survival times. Available:http://www.macmillan.org.uk/Documents/AboutUs/Newsroom/LivingAfterCancerMedianCancerSurvivalTimes.pdf. Accessed 20 June 2012.
8. Brambilla E, Travis WD, Colby TV, Corrin B, Shimosato Y, (2001) The new World Health Organization classification of lung tumours. European Respiratory Journal 18: 1059-1068.
9. Sos ML, Michel K, Zander T, Weiss J, Frommolt P, et al. (2009) Predicting drug susceptibility of non-small cell lung cancers based on genetic lesions. J Clin Invest 119: 1727-1740 doi:10.1172/JCI37127.
10. Sos ML, Fischer S, Ullrich R, Peifer M, Heuckmann JM, et al. (2009) Identifying genotype-dependent efficacy of single and combined PI3K- and MAPK-pathway inhibition in cancer. Proc Natl Acad Sci USA 106: 18351-18356 doi:10.1073/pnas.0907325106.
11. Churchill GA, (2002) Fundamentals of experimental design for cDNA microarrays. Nature Genetics 32: 490-495 doi:10.1038/ng1031.
12. Stekel D (2003) Microarray Bioinformatics. Cambridge University Press. 292 p.
13. Yang YH, Speed T, (2002) Design issues for cDNA microarray experiments. Nat Rev Genet 3: 579-588 doi:10.1038/nrg863.
14. Allison DB, Cui X, Page GP, Sabripour M, (2006) Microarray data analysis: from disarray to consolidation and consensus. Nat Rev Genet 7: 55-65 doi:10.1038/nrg1749.
15. Lusa L, Cappelletti V, Gariboldi M, Ferrario C, De Cecco L, et al. (2006) Questioning the utility of pooling samples in microarray experiments with cell lines. Int J Biol Markers 21: 67-73.
16. Shedden K, Chen W, Kuick R, Ghosh D, Macdonald J, et al. (2005) Comparison of seven methods for producing Affymetrix expression scores based on False Discovery Rates in disease profiling data. BMC Bioinformatics 6: 26 doi:10.1186/1471-2105-6-26.
17. Irizarry RA, Wu Z, Jaffee HA, (2006) Comparison of Affymetrix GeneChip expression measures. Bioinformatics 22: 789-794 doi:10.1093/bioinformatics/btk046.
18. Wu J, Gentry RI with contributions from JMJ (n.d.) gcrma: Background Adjustment Using Sequence Information.
19. Friedman J, Hastie T, Tibshirani R (2001) The elements of statistical learning. Springer Series in Statistics. p. Available:http://www-stat.stanford.edu~/tibs/book/preface.ps. Accessed 11 July 2012.
20. Bourgon R, Gentleman R, Huber W, (2010) Independent filtering increases detection power for high-throughput experiments. PNAS 107: 9546-9551 doi:10.1073/pnas.0914005107.
21. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, et al. (1999) Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. science 286: 531-537.
22. Han N, Dol Z, Vasieva O, Hyde R, Liloglou T, et al. (2012) Progressive lung cancer determined by expression profiling and transcriptional regulation. Int J Oncol 41: 242-252 doi:10.3892/ijo.2012.1421.
23. Hochberg Y, Benjamini Y, (1990) More powerful procedures for multiple significance testing. Stat Med 9: 811-818.
24. Buache E, Etique N, Alpy F, Stoll I, Muckensturm M, et al. (2011) Deficiency in trefoil factor 1 (TFF1) increases tumorigenicity of human breast cancer cells and mammary tumor development in TFF1-knockout mice. Oncogene 30: 3261-3273 doi:10.1038/onc.2011.41.
25. Everett CJ, Wells BJ, Frithsen IL, Koopman RJ, (2007) Smoking, fibrinogen and cancer mortality. J Natl Med Assoc 99: 328-333.
26. Verkman A, Hara-Chikuma M, Papadopoulos M, (2008) Aquaporins-new players in cancer biology. Journal of Molecular Medicine 86: 523-529 doi:10.1007/s00109-008-0303-9.
27. Murthy SRK, Pacak K, Loh YP, (2010) Carboxypeptidase E: elevated expression correlated with tumor growth and metastasis in pheochromocytomas and other cancers. Cell Mol Neurobiol 30: 1377-1381 doi:10.1007/s10571-010-9592-y.
28. Corona W, Karkera DJ, Patterson RH, Saini N, Trachiotis GD, et al. (2004) Analysis of Sciellin (SCEL) as a candidate gene in esophageal squamous cell carcinoma. Anticancer Res 24: 1417-1419.
29. Liu L, Liao G, He P, Zhu H, Liu P, et al. (2008) Detection of circulating cancer cells in lung cancer patients with a panel of marker genes. Biochemical and Biophysical Research Communications 372: 756-760 doi:10.1016/j.bbrc.2008.05.101.
30. Butler SL, Dong H, Cardona D, Jia M, Zheng R, et al. (2008) The antigen for Hep Par 1 antibody is the urea cycle enzyme carbamoyl phosphate synthetase 1. Laboratory Investigation 88: 78-88 doi:10.1038/labinvest.3700699.
31. Parkinson H, Sarkans U, Kolesnikov N, Abeygunawardena N, Burdett T, et al. (2011) ArrayExpress update-an archive of microarray and high-throughput sequencing-based functional genomics experiments. Nucleic Acids Res 39: D1002-1004 doi:10.1093/nar/gkq1040.
32. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, et al. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5: R80 doi:10.1186/gb-2004-5-10-r80.
33. Kauffmann A, Gentleman R, Huber W, (2009) arrayQualityMetrics-a bioconductor package for quality assessment of microarray data. Bioinformatics 25: 415-416 doi:10.1093/bioinformatics/btn647.
34. Hochreiter S, Clevert D-A, Obermayer K, (2006) A new summarization method for Affymetrix probe level data. Bioinformatics 22: 943-949 doi:10.1093/bioinformatics/btl033.
35. Gentleman R, Carey V, Huber W, Hahne F (n.d.) genefilter: genefilter: methods for filtering genes from microarray experiments.
36. Smyth G (2005) Limma: linear models for microarray data. Bioinformatics and computational biology solutions using R and Bioconductor: 397-420.